General contact

Head Office
Novartis International AG
CH-4002 Basel
Switzerland

+41 61 324 11 11
+41 61 324 80 01
Monday - Friday,
8:30 - 17:00, GMT+1
(Central European Time)

Investors

Novartis International AG
Investor Relations
P.O. Box
CH-4002 Basel
Switzerland

+41 61 324 79 44

Media

Global Media Relations
Eric Althoff
Basel, Switzerland

+41 61 324 7999

Reporting side effects

Report a suspected side effect (also known as an adverse event) related to a Novartis Pharmaceutical drug or a Novartis Vaccine.

Reporting side effects

pane 4 content

Corporate responsibility

During the past 10 years, Novartis sales have more than doubled, but our emissions and use of natural resources have grown much more slowly. We aim to use natural resources efficiently and minimize the environmental impacts of our activities and products during their life cycles.

Solar panels in Vacaville, California, US

Novartis new solar generating system in Vacaville California
Novartis new solar generating system in Vacaville California
Novartis new solar generating system in Vacaville California
Companys largest solar initiative, Vacaville California
Companys largest solar initiative, Vacaville California
Companys largest solar initiative, Vacaville California
Novartis solar initiative, Vacaville California
Novartis solar initiative, Vacaville California
Novartis solar initiative, Vacaville California

Novartis Solar Power in East Hanover, New Jersey, US

Solar power, East Hanover
Solar power, East Hanover
Solar power, East Hanover

Carbon offset project in Argentina

Planted Trees, Argentina, aerial view
Planted Trees, Argentina, aerial view
Planted Trees, Argentina, aerial view
Carbon offset project, Argentina
Carbon offset project, Argentina
Carbon offset project, Argentina
Planted Trees, Argentina
Planted Trees, Argentina
Planted Trees, Argentina
You may use the multimedia material provided in this section for commercial purposes only in relation to Novartis. These images must not be modified in any way and each item must have the copyright acknowledgement of Novartis AG (© Novartis AG).